Compare ALMR & PLUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALMR | PLUS |
|---|---|---|
| Founded | 2018 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Retail: Computer Software & Peripheral Equipment |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.5B |
| IPO Year | 2026 | 1996 |
| Metric | ALMR | PLUS |
|---|---|---|
| Price | $28.64 | $95.71 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $37.00 | N/A |
| AVG Volume (30 Days) | ★ 674.6K | 192.5K |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 1.11% |
| EPS Growth | N/A | ★ 24.20 |
| EPS | N/A | ★ 2.72 |
| Revenue | N/A | ★ $2,442,549,000.00 |
| Revenue This Year | $64.80 | $4.67 |
| Revenue Next Year | $37.27 | $4.89 |
| P/E Ratio | ★ N/A | $35.49 |
| Revenue Growth | N/A | ★ 18.07 |
| 52 Week Low | $21.58 | $73.09 |
| 52 Week High | $39.61 | $99.64 |
| Indicator | ALMR | PLUS |
|---|---|---|
| Relative Strength Index (RSI) | 45.59 | 53.71 |
| Support Level | $23.87 | $84.98 |
| Resistance Level | $29.06 | $97.08 |
| Average True Range (ATR) | 2.38 | 4.06 |
| MACD | -0.06 | 0.31 |
| Stochastic Oscillator | 47.77 | 81.12 |
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.
ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.